Anjarium Biosciences Company
Anjarium Biosciences is a company that is developing a new type of non-viral gene therapy to treat genetic diseases. They are using bioinspired nanomedicine to address a range of genetic diseases, including those that require large gene delivery. Their platform aims to provide benefits to patients that have previously been out of reach by addressing key deficiencies of viral gene therapies. Anjarium Biosciences is pioneering the next generation of non-viral gene therapy by targeting more diseases, more precisely, and in a more personalized way.
Connections
Founded Date:
2017
Headquarters:
Schlieren
Technology:
Gene Therapy
Employee Number:
1-10
Industry:
BioTech
Estimated Revenue:
$105M. When
Total Funding:
$60.4M